Walleye Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,800
Closed -$294K 1544
2019
Q4
$294K Buy
13,800
+3,800
+38% +$85.1K 0.02% 934
2019
Q3
$230K Buy
+10,000
New +$213K 0.01% 1136

Other funds holding SBRA

Walleye Capital's SBRA Position: Q2 2025 in Review

Walleye Capital sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 96,627 shares — an estimated $1.69M sold.

Walleye Capital first reported a position in SBRA in Q4 2019 and held it in 14 quarters. The position peaked at $2.63M in Q2 2022. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Walleye Capital reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 96,627 Sabra Healthcare REIT shares in Q2 2025, an estimated $1.69M.
  • Walleye Capital first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 14 quarters.
  • Walleye Capital's Sabra Healthcare REIT position peaked at $2.63M in Q2 2022.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.